Positron Emission Tomography (PET) Market 2023 | Size, Top Companies, Demand and Opportunity 2028
IMARC Group's report titled "Positron Emission Tomography (PET) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028".The global positron emission tomography market size reached US$ 1,084 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,512 Million by 2028, exhibiting a growth rate (CAGR) of 5.9% during 2023-2028.
Factors Affecting the Growth of the Positron Emission Tomography Industry:- Continuous Technological Advancements:
The positron emission tomography (PET)
industry is currently experiencing substantial growth, largely driven by rapid
technological advancements. Innovations in PET imaging technology, including
the development of high-resolution detectors and advanced software algorithms,
are enhancing the quality and accuracy of imaging. These improvements
facilitate early and more precise diagnosis of diseases, particularly in
oncology, neurology, and cardiology. Additionally, the integration of PET with
other imaging modalities like MRI and CT is opening new avenues for hybrid
imaging, thereby expanding clinical applications. This technological evolution
is improving patient outcomes and propelling the industry's growth by creating
new market opportunities and attracting investment.
- Increased Prevalence of Chronic Diseases:
The growing incidence of chronic diseases such
as cancer, cardiovascular diseases, and neurological disorders is another key
factor supporting the growth of the PET industry. PET scans play a crucial role
in the early detection and management of these diseases, offering detailed
insights into the physiological processes of the body. As the global population
ages and lifestyle-related diseases become more prevalent, the demand for
effective diagnostic tools like PET scans is escalating. This trend is prompting
healthcare providers to invest in PET technology, contributing to market
growth. Furthermore, the rising awareness about the importance of early
diagnosis in improving treatment outcomes is augmenting the demand for PET
imaging, thereby favoring market growth.
- Rising Government and Regulatory Support:
The PET industry's growth is being
significantly influenced by supportive government policies and regulatory
frameworks. Governments worldwide are increasingly recognizing the importance
of advanced diagnostic methods in improving healthcare outcomes. This
acknowledgment is leading to favorable policies, funding, and initiatives aimed
at encouraging research and development (R&D) in the field of nuclear
medicine and imaging technologies. Furthermore, regulatory bodies are
streamlining approval processes for new PET imaging agents and equipment,
facilitating quicker market entry and adoption. Such government and regulatory
support stimulates market growth and drives continuous innovation, ensuring
that the latest and most effective PET technologies are available for patient
care.
Leading Companies Operating in the Global
Positron Emission Tomography Industry:
- Agfa Healthcare (Dedalus Group)
- GE Healthcare
- Koninklijke Philips NV
- Neusoft Medical Systems
- Positron Corporation
- Oncovision (Bruker)
- Mediso Medical Imaging Systems Ltd.
- Siemens Healthineers AG
- Segami Corporation, Hitachi Ltd.
For an in-depth analysis, you can refer sample
copy of the report: https://www.imarcgroup.com/positron-emission-tomography-market/requestsample
Positron Emission Tomography Market Report
Segmentation:
By Product Type:
- Full Ring PET Scanners
- Partial Ring PET Scanners
On the basis of the product type, the market
has been bifurcated into full and partial ring PET scanners.
By Detector Type:
- Bismuth Germanium Oxide (BGO)
- Lutetium Oxyorthosilicate (LSO)
- Lutetium Fine Silicate (LFS)
- Lutetium Yttrium Orthosilicate (LYO)
- Gadolinium Oxyorthosilicate (GSO)
Based on the detector type, the market has
been classified into Bismuth Germanium Oxide (BGO), Lutetium Oxyorthosilicate
(LSO), Lutetium Fine Silicate (LFS), Lutetium Yttrium Orthosilicate (LYO) and
Gadolinium Oxyorthosilicate (GSO).
By Application:
- Cardiology
- Neurology
- Oncology
- Others
Oncology represents the largest market segment
due to the growing prevalence of cancer globally and the critical role of PET
scans in the accurate diagnosis, staging, and treatment monitoring of various
types of cancers.
By End User:
- Hospitals and Clinics
- Diagnostic Centers
- Others
The market has been divided based on the end
user into hospitals and clinics, diagnostic centers, and others.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia,
Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia,
Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=2284&flag=C
Global Positron Emission Tomography Market
Trends:
The positron emission tomography (PET) market
is currently witnessing several dynamic trends. There is a growing emphasis on
the development of PET/MRI systems, combining the functional imaging
capabilities of PET with the superior soft tissue contrast of MRI. This hybrid
technology is enhancing diagnostic accuracy, particularly in oncology and
neurology, thereby accelerating market growth. Additionally, the market is
seeing an increased focus on developing new radiotracers that provide more
detailed insights into various diseases. In line with this, the ongoing
expansion of PET applications beyond oncology into cardiology and neurology is
another key factor catalyzing the market growth. These developments are spurred
by continuous research and innovation, aiming to broaden the scope and efficacy
of PET imaging, thus fostering market growth.
Note: If you need specific information that is
not currently within the scope of the report, we will provide it to you as a
part of the customization.
About Us:
IMARC Group is a leading market research company that offers management
strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most
critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and
technological developments for business leaders in pharmaceutical, industrial,
and high technology organizations. Market forecasts and industry analysis for
biotechnology, advanced materials, pharmaceuticals, food and beverage, travel
and tourism, nanotechnology and novel processing methods are at the top of the
companys expertise.
Our offerings include comprehensive market intelligence in the form of research
reports, production cost reports, feasibility studies, and consulting services.
Our team, which includes experienced researchers and analysts from various
industries, is dedicated to providing high-quality data and insights to our
clientele, ranging from small and medium businesses to Fortune 1000
corporations.
Contact Us:
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
Comments
Post a Comment